These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 10575562)

  • 21. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes.
    Hnatyszyn HJ
    Antivir Ther; 2005; 10(1):1-11. PubMed ID: 15751759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms in the IFNAR1 gene in patients with chronic hepatitis C: outcome of combined IFN-alpha therapy.
    Tena-Tomás C; Pedroso ML; de Messias-Reason IJ; Kremsner PG; Kun JF
    Eur Cytokine Netw; 2007 Sep; 18(3):136-41. PubMed ID: 17823081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of patients with HCV infection poorly tolerant to recombinant interferon alpha.
    Cagnoni C; Pancotti D; Carrara G
    Hepatogastroenterology; 2000; 47(31):199-203. PubMed ID: 10690609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Eradication of hepatitis C virus after 3 months of interferon treatment in a patient with chronic hepatitis C].
    Winkfield B; Lunel F; Beurrier P; Calès P
    Gastroenterol Clin Biol; 2000 Jan; 24(1):136-7. PubMed ID: 10755865
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy of chronic hepatitis C].
    Ferenci P
    Wien Med Wochenschr; 2000; 150(23-24):481-5. PubMed ID: 11205179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C treatment completion rates in routine clinical care.
    Ridruejo E
    Liver Int; 2010 Aug; 30(7):1082; author reply 1083. PubMed ID: 20214733
    [No Abstract]   [Full Text] [Related]  

  • 27. [Short-time hepatitis C treatment and drug abuse].
    Kristensen Ø; Rysstad O; Gallefoss F
    Tidsskr Nor Laegeforen; 2009 Dec; 129(23):2498; author reply 2499. PubMed ID: 19997144
    [No Abstract]   [Full Text] [Related]  

  • 28. Interferon alfa: effects of long-term treatment for polycythemia vera.
    Silver RT
    Semin Hematol; 1997 Jan; 34(1):40-50. PubMed ID: 9025161
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-hepatitis push raises ethical issues.
    Jaklevic MC
    Mod Healthc; 1998 Nov; 28(48):2-3. PubMed ID: 10187704
    [No Abstract]   [Full Text] [Related]  

  • 30. [Alfa-interferons. Genetically engineered Antivirals].
    Dingermann T; Zündorf I
    Pharm Unserer Zeit; 2011 Jan; 40(1):68-77. PubMed ID: 21194085
    [No Abstract]   [Full Text] [Related]  

  • 31. Entering a new era in the treatment of hepatitis C.
    Colombo M; Peck-Radosavljevic M
    Dig Liver Dis; 2014 Dec; 46 Suppl 5():S157. PubMed ID: 25453868
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic variations in heme oxygenase-1 and chronic hepatitis.
    Bonkovsky HL; Lambrecht RW; Naishadham D
    Hepatology; 2010 Jul; 52(1):400-1. PubMed ID: 20232486
    [No Abstract]   [Full Text] [Related]  

  • 33. The efficacy, limitations, and outcomes of our current interferon-based therapies for hepatitis C.
    Kwo PY; Sozio MS
    Gastroenterology; 2013 Dec; 145(6):1488-90. PubMed ID: 24409497
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment for elderly patients with hepatitis C virus].
    Arase Y
    Nihon Shokakibyo Gakkai Zasshi; 2011 Jul; 108(7):1179-86. PubMed ID: 21737972
    [No Abstract]   [Full Text] [Related]  

  • 35. Interferon alfacon-1: new preparation. Basically a me-too interferon alfa.
    Prescrire Int; 2003 Jun; 12(65):95-6. PubMed ID: 12825573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
    Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reversible ageusia and hyposmia induced by interferon in a patient with chronic hepatitis C].
    Irigoien Aleixandre S; Castiella Eguzkira A; Fernández Fernández FJ
    Rev Esp Enferm Dig; 2003 May; 95(5):364-8. PubMed ID: 12828524
    [No Abstract]   [Full Text] [Related]  

  • 38. Improving anti-HCV therapy.
    Pol S; Mallet VO
    Discov Med; 2006 Oct; 6(35):187-90. PubMed ID: 17234140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of chronic hepatitis C treated with interferon.
    Hadziyannis SJ; Papatheodoridis GV
    Ital J Gastroenterol Hepatol; 1999; 31(6):459-61. PubMed ID: 10575562
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.